levobunolol has been researched along with Incontinentia Pigmenti Achromians in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apple, DJ; Chirila, TV; Constable, IJ; Crawford, GJ; Hicks, CR; Werner, L | 1 |
| Doyle, E; Liu, C | 1 |
2 other study(ies) available for levobunolol and Incontinentia Pigmenti Achromians
| Article | Year |
|---|---|
Deposits in artificial corneas: risk factors and prevention.
Topics: Adrenergic beta-Antagonists; Artificial Organs; Biocompatible Materials; Calcinosis; Calcium; Cornea; Glucocorticoids; Humans; Levobunolol; Pigmentation Disorders; Polymethyl Methacrylate; Retrospective Studies; Risk Factors; Smoking | 2004 |
A case of acquired iris depigmentation as a possible complication of levobunolol eye drops.
Topics: Adrenergic beta-Antagonists; Aged; Humans; Hypopigmentation; Iris Diseases; Levobunolol; Male; Pigmentation Disorders | 1999 |